NCT05394519 ClinicalTrials.gov
Current evidence does not support the use of B12 as a weight loss intervention, and B12 products have no licensed indication for weight loss in the UK
The FDA proposed to exclude semaglutide (Wegovy, Ozempic), tirzepatide (Zepbound, Mounjaro), and liraglutide (Saxenda, Victoza), popular glucagon-like peptide-1 (GLP-1) medications, from the 503B bulk list, citing a lack of clinical need for outsourcing facilities to compound these medications from bulk drug substances
Research indicates that TB-500 reduces inflammation markers in seminal fluid while promoting tissue regeneration in the reproductive tract
Scientific findings on using B12 for weight loss have mixed results
Popular Peptides Lets run through the most popular peptides people are taking now and what they do